Vext Science Inc (VV5) - Total Liabilities
Based on the latest financial reports, Vext Science Inc (VV5) has total liabilities worth €59.68 Million EUR (≈ $69.77 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vext Science Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how Vext Science Inc's total liabilities have evolved over time, based on quarterly financial data. See Vext Science Inc (VV5) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Vext Science Inc Competitors by Total Liabilities
The table below lists competitors of Vext Science Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INSPIREMD 1/18 DL-0001
F:II2
|
Germany | €14.20 Million |
|
Good Way Technology Co Ltd
TWO:3272
|
Taiwan | NT$3.64 Billion |
|
B.M.P. PHARMA TRAD (BMP.SG)
STU:BMP
|
Germany | €3.77 Million |
|
Banimmo SA
BR:BANI
|
Belgium | €129.32 Million |
|
Scandium International Mining Corp
F:0E6
|
Germany | €2.05 Million |
|
Valartis Group AG
SW:VLRT
|
Switzerland | CHF38.48 Million |
|
K2A Knaust & Andersson Fastigheter AB (publ)
ST:K2A-PREF
|
Sweden | Skr4.87 Billion |
|
4C Group AB
ST:4C
|
Sweden | Skr248.63 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Vext Science Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vext Science Inc (VV5) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vext Science Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vext Science Inc (2017–2024)
The table below shows the annual total liabilities of Vext Science Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €61.23 Million ≈ $71.59 Million |
+12.19% |
| 2023-12-31 | €54.58 Million ≈ $63.81 Million |
+12.30% |
| 2022-12-31 | €48.60 Million ≈ $56.82 Million |
+99.91% |
| 2021-12-31 | €24.31 Million ≈ $28.42 Million |
+27.00% |
| 2020-12-31 | €19.14 Million ≈ $22.38 Million |
+46.04% |
| 2019-12-31 | €13.11 Million ≈ $15.32 Million |
+103.73% |
| 2018-12-31 | €6.43 Million ≈ $7.52 Million |
+26.99% |
| 2017-12-31 | €5.07 Million ≈ $5.92 Million |
-- |
About Vext Science Inc
Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more